Harvard Bioscience HBIO Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue estimate$19.0M
EPS estimate-$0.03
Next report
Aug 10, 2026 (In 4 weeks)Revenue estimate$21.5M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
Ask the moment Harvard Bioscience reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Harvard Bioscience report Q2 2025 earnings?
- Harvard Bioscience (HBIO) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Harvard Bioscience's Q2 2025 revenue and EPS?
- Harvard Bioscience reported revenue of $20.5M and diluted EPS of $-0.01 for Q2 2025.
- Did Harvard Bioscience beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $19.0M by $1.5M. EPS beat the consensus estimate of $-0.03 by $0.02.
- How did Harvard Bioscience's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 11.5% from $23.1M a year earlier and diluted EPS grew 66.7% from $-0.03.
- Where can I find Harvard Bioscience's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001171843-25-005287) directly on SEC EDGAR. The filing index links above go to sec.gov.